{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:14:16Z","timestamp":1761765256522},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T00:00:00Z","timestamp":1261958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00066-009-2023-7","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T04:00:51Z","timestamp":1263528051000},"page":"46-52","source":"Crossref","is-referenced-by-count":23,"title":["Longitudinal Analysis of Quality of Life in Patients Receiving Conformal Radiation Therapy for Prostate Cancer"],"prefix":"10.1007","volume":"186","author":[{"given":"Hans","family":"Geinitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Thamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Prause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Kerndl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymonde","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Molls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank B.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"2023_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"N.K. Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"2023_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1200\/JCO.1997.15.1.223","volume":"15","author":"C.J. Beard","year":"1997","unstructured":"Beard CJ, Propert KJ, Rieker PP, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997;15:223\u20139.","journal-title":"J Clin Oncol"},{"key":"2023_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00066-008-1837-z","volume":"184","author":"M. Bohrer","year":"2008","unstructured":"Bohrer M, Schroder P, Welzel G, et al. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer. Strahlenther Onkol 2008;184:674\u20138.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR4","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00520-007-0229-8","volume":"15","author":"C. Danjoux","year":"2007","unstructured":"Danjoux C, Gardner S, Fitch M. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer. Support Care Cancer 2007;15:1169\u201376.","journal-title":"Support Care Cancer"},{"key":"2023_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00066-004-1254-x","volume":"180","author":"R.M. Galalae","year":"2004","unstructured":"Galalae RM, Loch T, Riemer B, et al. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol 2004;180:582\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0360-3016(01)01657-1","volume":"51","author":"H. Geinitz","year":"2001","unstructured":"Geinitz H, Zimmermann F, Stoll P, et al. Fatigue, serum cytokine levels and blood cell counts during radiation therapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 2001;51:691\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.radonc.2005.06.001","volume":"76","author":"H. Geinitz","year":"2005","unstructured":"Geinitz H, Zimmermann F, Thamm R, et al. 3-D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol 2005;76:27\u201334.","journal-title":"Radiother Oncol"},{"key":"2023_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.radonc.2006.05.004","volume":"79","author":"H. Geinitz","year":"2006","unstructured":"Geinitz H, Zimmermann F, Thamm R, et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. Radiother Oncol 2006;79:341\u20137.","journal-title":"Radiother Oncol"},{"key":"2023_CR9","first-page":"I","volume":"145","author":"A. Glaus","year":"1998","unstructured":"Glaus A. Fatigue in patients with cancer. Analysis and assessment. Recent Results Cancer Res 1998;145:I\u2013172.","journal-title":"Recent Results Cancer Res"},{"key":"2023_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00066-009-1970-3","volume":"185","author":"G. Goldner","year":"2010","unstructured":"Goldner G, Bombosch V, Geinitz H, et al. Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial. Strahlenther Onkol 2010;185:94\u2013100.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00066-006-1607-8","volume":"182","author":"G. Goldner","year":"2006","unstructured":"Goldner G, Wachter S, Wachter-Gerstner N, et al. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy). Strahlenther Onkol 2006;182:537\u201342.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/cncr.21364","volume":"104","author":"J.T. Hickok","year":"2005","unstructured":"Hickok JT, Roscoe JA, Morrow GR, et al. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 2005;104:1772\u20138.","journal-title":"Cancer"},{"key":"2023_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00066-008-1896-1","volume":"184","author":"A. Hille","year":"2008","unstructured":"Hille A, Herrmann MK, Kertesz T, et al. Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation. Strahlenther Onkol 2008;184:686\u201392.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/1097-0142(20000915)89:6<1322::AID-CNCR18>3.0.CO;2-D","volume":"89","author":"M. Janda","year":"2000","unstructured":"Janda M, Gerstner N, Obermair A, et al. Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 2000;89:1322\u20138.","journal-title":"Cancer"},{"key":"2023_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1464-410X.2005.05565.x","volume":"96","author":"V.A. Jenkins","year":"2005","unstructured":"Jenkins VA, Bloomfield DJ, Shilling VM, et al. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 2005;96:48\u201353.","journal-title":"BJU Int"},{"key":"2023_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ijc.21043","volume":"116","author":"I. Korfage","year":"2005","unstructured":"Korfage I, Essink-Bot ML, Borsboom GJJM, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005;116:291\u20136.","journal-title":"Int J Cancer"},{"key":"2023_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00066-004-1226-1","volume":"180","author":"V.E. Kouloulias","year":"2004","unstructured":"Kouloulias VE, Kouvaris JR, Pissakas G, et al. A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity. Strahlenther Onkol 2004;180:557\u201362.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijrobp.2007.04.013","volume":"69","author":"I. Lips","year":"2007","unstructured":"Lips I, Dehnad H, Kruger AB, et al. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2007;69:656\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1464-410X.2008.08117.x","volume":"103","author":"I.M. Lips","year":"2009","unstructured":"Lips IM, van Gils CH, van der Heide UA, et al. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification. BJU Int 2009;103:762\u20137.","journal-title":"BJU Int"},{"key":"2023_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00066-005-1313-y","volume":"181","author":"P. Mavroidis","year":"2005","unstructured":"Mavroidis P, al-Abany M, Helgason AR, et al. Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Strahlenther Onkol 2005;181:293\u2013306.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejca.2004.10.017","volume":"41","author":"D. Osoba","year":"2005","unstructured":"Osoba D, Bezjak A, Brundage M, et al. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer 2005;41:280\u20137.","journal-title":"Eur J Cancer"},{"key":"2023_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","volume":"61","author":"S.T. Peeters","year":"2005","unstructured":"Peeters ST, Heemsbergen WD, van Putten WLJ, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 to 78 Gy. Int J Radiat Oncol Biol Phys 2005;61:1019\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.radonc.2007.10.022","volume":"88","author":"M. Pinkawa","year":"2008","unstructured":"Pinkawa M, Fischedick K, Asadpour B, et al. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer \u2014 a prospective analysis. Radiother Oncol 2008;88:135\u20139.","journal-title":"Radiother Oncol"},{"key":"2023_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00066-009-1894-y","volume":"185","author":"M. Pinkawa","year":"2010","unstructured":"Pinkawa M, Piroth MD, Asadpour B, et al. Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis. Strahlenther Onkol 2010;185:101\u20138.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M. I. Roach","year":"2006","unstructured":"Roach M III, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s00520-006-0085-y","volume":"14","author":"J.A. Sloan","year":"2006","unstructured":"Sloan JA, Frost MH, Berzon R, et al. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 2006;14:988\u201398.","journal-title":"Support Care Cancer"},{"key":"2023_CR27","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/cncr.11805","volume":"98","author":"I. Staff","year":"2003","unstructured":"Staff I, Salner SA, Bohannon R, et al. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy. Cancer 2003;98:2335\u201343.","journal-title":"Cancer"},{"key":"2023_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1464-410X.2006.06560.x","volume":"99","author":"R.J. Stephens","year":"2007","unstructured":"Stephens RJ, Dearnaley DP, Cowan R, et al. The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397). BJU Int 2007;99:301\u201310.","journal-title":"BJU Int"},{"key":"2023_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0360-3016(01)01821-1","volume":"52","author":"S. Wachter","year":"2002","unstructured":"Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91\u2013100.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0360-3016(95)02002-5","volume":"33","author":"B. D. Watkins","year":"1995","unstructured":"Watkins Bruner D, Scott C, Lawton CA, et al. RTOG\u2019s first quality of life study \u2014 RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:901\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00066-007-1672-7","volume":"183","author":"W. Weiss","year":"2007","unstructured":"Weiss W, Horninger W, Forthuber BC, et al. Single-institution results of primary external-beam radiation for the treatment of T1-T3 prostate cancer. Strahlenther Onkol 2007;183:321\u20136.","journal-title":"Strahlenther Onkol"},{"key":"2023_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/cncr.20378","volume":"101","author":"P.M. Windsor","year":"2004","unstructured":"Windsor PM, Nicol KF, Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004;101:550\u20137.","journal-title":"Cancer"},{"key":"2023_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijrobp.2003.10.008","volume":"59","author":"C. Wratten","year":"2004","unstructured":"Wratten C, Kilmurray J, Nash S, et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys 2004;59:160\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-2023-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2023-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:30:55Z","timestamp":1558578655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-2023-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-2023-7","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}